Washington University begins recruiting participants for phase 3 COVID-19 investigational vaccine clinical trial
Washington University School of Medicine in St. Louis is a testing site for the Janssen Pharmaceutical Companies of Johnson &
Read more
Finland’s Covid sniffer dog trial ‘extremely positive’: researchers
A pilot project using sniffer dogs to provide instant and pain-free coronavirus testing at Helsinki airport has shown promising early
Read more
FDA Authorises Restart of the COVID-19 AZD1222 Vaccine US Phase III Trial
23 October 2020 — Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators
Read more
U.S. COVID-19 Vaccine Trial Enrolls 30,000
THURSDAY, Oct. 22, 2020 — The first company to start a phase 3 trial of a COVID-19 vaccine reached its
Read more
Anti-siglec-8 antibody trial shows promise for treating eosinophilic gastritis and duodenitis
Eosinophilic gastritis and duodenitis are inflammatory diseases characterized by high levels of eosinophils and mast cells (immune system cells) in
Read more
1st patient treated in Rejuvenair trial for COPD with chronic bronchitis
Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir System for the
Read more
Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations
Read more
Trial finds benefit of immunotherapy-chemotherapy combination in early-stage triple-negative breast cancer
Adding an immunotherapy agent to a three-drug chemotherapy regimen can improve the likelihood that early-stage triple-negative breast cancer will recede
Read more
Genetics research produces clinical trial for ‘childhood Alzheimer’s’
An arthritis drug is to be trialed as a treatment for children with a fatal metabolic disorder which causes neurological
Read more
Citing lack of benefit, NIH halts trial of hydroxychloroquine for COVID-19
(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long
Read more